Avalyn Pharma Inc.

Operating income

(33)

10-Q filed Nov 12, 2026

Net income

(30)

10-Q filed Nov 12, 2026

Free cash flow

(26)

10-Q filed Nov 12, 2026

31.57 USDLast IEX trade of Nov 11, 2026

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms